Eli Lilly & Co. shares gained as its main rival in weight-loss drugs posted disappointing results from a clinical trial.
Lilly Rises After Novo Trial Miss Boosts Its Weight Loss Edge
Estimated read time
1 min read
You May Also Like
TSMC Shares Touch Record High, Eying Best Year Since 1999 on AI
December 24, 2024
Bitcoin Momentum Ebbs Heading Into Last Stretch of Record Year
December 24, 2024
UK launches review of targets for sales of electric vehicles
December 24, 2024
+ There are no comments
Add yours